Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government. The...
The ASX cared little for Wall Street’s overnight rally, with the S&P/ASX200 lowering its colours by 34.10 points or 0.48% to 7,042.40. The index has...
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after receiving the results of dose simulation studies that support the potential efficacy of...
AdAlta Ltd (ASX:1AD) has received results of dose simulation studies that support the potential efficacy of its i-body drug candidate AD-214 in fibrotic...
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham tells Proactive the company has wrapped up the enrolment of healthy volunteers for its AD-214 Phase 1 extension...